Trial Profile
A Prospective Randomized Trial to Analyze the Effect of the Gonadotropin Administered During Control Ovarian Stimulation on Embryo Kinetics of Development
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2023
Price :
$35
*
At a glance
- Drugs Corifollitropin alfa (Primary) ; Follitropin beta (Primary) ; Menotropin (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms PEM-ESD
- 09 Aug 2022 Status changed from recruiting to discontinued.
- 02 Apr 2015 New trial record